Biotech
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 02/12/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company"), is pleased to announce that its French subsidiary, Immutep ...
CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 02/10/17 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for di ...
HUDSON, NY: HUDSON, NY -- (Marketwired) -- 02/08/17 -- Taconic Biosciences, a global leader in genetically engineered murine models and associated services, announced the launch of the program, providing resear ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 02/08/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the year ended November 30, 2016.Fiscal year 2016 fina ...
CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 02/07/17 -- Marina Biotech, Inc. (OTCQB: MRNA) a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for dis ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 02/07/17 -- VBI Vaccines Inc. (NASDAQ: VBIV) (TSX: VBV) ("VBI") announced today the receipt of positive Scientific Advice from the Committee fo ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 02/07/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/07/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL) a clinical stage immuno-oncology company developing innovative therapies for the treatment of can ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 02/06/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
HALIFAX, NOVA SCOTIA: University Health Network (UHN) in Toronto to Launch Triple-Combination Study Evaluating the Potential for Enhanced Anti-Cancer Activity of Currently Marketed Checkpoint Inhibitor When Combined With D ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 02/03/17 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy com ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 02/02/17 -- Immunovaccine Inc. (TSX: IMV) (OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will participate in this ...
TORONTO, ONTARIO: - Advancing the two ongoing clinical trials with TTI-621, an IgG1 SIRPaFc fusion protein targeting CD47; updated data anticipated in 2H/2017 - Expanding the CD47 franchise with TTI-622, an IgG4 SIRPaF ...
MIAMI, FL: $1.8M Gross Income and $1.0M Net Profit Year to Date. ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 01/31/17 -- Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 01/31/17 -- (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to assess the efficacy of its lead i ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/31/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of canc ...
SCOTTSDALE, ARIZONA: New core product sales increase 147% fourth quarter over fourth quarter ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/30/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, dev ...
